Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Venom from honeybees found to kill aggressive breast cancer cells – Australian research published in Nature Precision Oncology
Honeybee venom induces cancer cell death in hard to treat triple-negative breast cancer with minimal effect on healthy…
New Potential Treatment Found for Cancer and Inflammatory Diseases
QIMR Berghofer-led research has discovered the pivotal role played by an important immune system protein…
Researchers identify mechanism underlying cancer cells’ immune evasion
Researchers in China have discovered how brain cancer cells increase production of a key protein…
Mouth cancer rates soar over 20 years in UK
A new Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68* per cent in the UK over…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.